US-based medical equipment manufacturer Stryker has secured the US Food and Drug Administration (FDA) 510(k) clearance for its Incompass Total Ankle System.

The Incompass implant is designed for patients with ankle joints affected by severe rheumatoid, post-traumatic, or degenerative arthritis.

The system combines the advanced technologies of Stryker’s Inbone and Infinity systems, offering a comprehensive solution for total ankle replacement.

It integrates Adaptis Boney Ingrowth Technology and redesigned tools to enhance long-term fixation, surgical adaptability, and workflow efficiency.

The system addresses key challenges in total ankle replacement and is informed by data from over 85,000 CT scans and 100,000 clinical cases.

It also provides a wide range of implant and instrumentation options tailored for patient-specific care.

Stryker Foot & Ankle business vice president and general manager Adam Jacobs said: “Incompass reflects our commitment to redefining what’s possible in total ankle replacement.

“By building on decades of clinical experience and leveraging extensive data insights, we’re setting a new standard, one that empowers surgeons to deliver more personalised care with greater efficiency and confidence.”

Incompass was developed using the Stryker Orthopaedic Modelling & Analytics (SOMA) platform, along with arthritic ankle scans from the Prophecy Surgical Planning System.

The system offers a continuum of implant and instrument choices, designed to suit both surgeon preferences and patient anatomy.

It comes with enhancements including a redesigned alignment system for improved control, updated implant holders, and refined tools to reduce surgical steps and setup time.

Recently, Stryker introduced the AXS Lift Intracranial Base Catheter, an advanced device to simplify neurovascular access and improve the delivery of interventional therapies.

The catheter provides stable support from the groin puncture to the cavernous segment of the internal carotid artery, minimising the need for multiple catheters in complex procedures. To simplify accessing the brain from the puncture site, Stryker collaborated with top physicians to create a new category of catheters, dubbed Intracranial Base Catheters.